Literature DB >> 11985334

Pharmacometric analysis of alpha1-adrenoceptor function in rat tail artery pretreated with lipopolysaccharides.

G Grześk1, L Szadujkis-Szadurski.   

Abstract

The inhibitory effect of lipopolysaccharides (LPS) on contraction evoked by alpha-adrenergic stimulation is quite well-known, but molecular mechanism of this inhibition is unclear. In the present study, an interaction between alpha-adrenoceptor response and LPS in rat tail artery was investigated using chemical stimulation. In the presence of LPS noradrenaline and phenylephrine, concentration-response curves were shifted to the right with a change in maximal responses. The K(A) and K(B) values calculated in the presence and absence of LPS did not differ significantly. The results strongly suggest that LPS did not change the affinity of alpha-adrenoceptors. Changes in the plot showing relationship between agonist-evoked responses and receptor occupancy in the presence of LPS and reduction of K(A)/ED50 value suggest reduction of alpha-adrenoceptor reserve. In the experiments performed on arteries without endothelium, the inhibitory effect of LPS was still present. In the presence of atropine, antazoline and indomethacin, the reduction of alpha-adrenoceptor reserve was noted, but in the presence of N-omega-nitro-L-arginine methyl ester (L-NAME), the inhibitory effect of LPS was not significant. Moreover, in LPS-pretreated arteries, in the presence of L-NAME, the increase in the receptor reserve was observed. It suggests that inhibitory effect of LPS is partially reversible. The results strongly indicate that in early endotoxemia, main inhibitory effect of LPS is connected with releasing nitric oxide and decreasing coupling between alpha1-adrenoceptor and signal induction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11985334

Source DB:  PubMed          Journal:  Pol J Pharmacol        ISSN: 1230-6002


  6 in total

1.  Effect of 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzene-sulfonamide on calcium influx in three contraction models.

Authors:  Elżbieta Grześk; Katarzyna Szadujkis-Szadurska; Michał Wiciński; Bartosz Malinowski; Thabit A Sinjab; Barbara Tejza; Maciej Pujanek; Ewa Janiszewska; Anna Kopczyńska; Grzegorz Grześk
Journal:  Biomed Rep       Date:  2015-11-10

2.  Comparison of the post-mortem interval on the effect of vascular responses to the activation of ionotropic and metabotropic receptors.

Authors:  Elżbieta Bloch-Bogusławska; Elżbieta Grześk; Grzegorz Grześk
Journal:  Biomed Rep       Date:  2014-12-03

3.  2,4,6-Trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide increases calcium influx in lipopolisaccharide-pre-treated arteries.

Authors:  Elżbieta Grześk; Katarzyna Szadujkis-Szadurska; Elżbieta Bloch-Bogusławska; Michał Wiciński; Bartosz Malinowski; Sylwia KołTan; Barbara Tejza; Maciej Pujanek; Grzegorz GrześK
Journal:  Exp Ther Med       Date:  2016-12-19       Impact factor: 2.447

4.  Role of acetylcholine and calcium ions in three vascular contraction models: Angiotensin II, phenylephrine and caffeine.

Authors:  Katarzyna Szadujkis-Szadurska; Grzegorz Grzesk; Leszek Szadujkis-Szadurski; Marta Gajdus; Grzegorz Matusiak
Journal:  Exp Ther Med       Date:  2012-05-11       Impact factor: 2.447

5.  The Modulatory Effect of Ischemia and Reperfusion on Arginine Vasopressin-Induced Arterial Reactions.

Authors:  Katarzyna Szadujkis-Szadurska; Bartosz Malinowski; Małgorzata Piotrowska; Grzegorz Grześk; Michał Wiciński; Marta Gajdus
Journal:  Biomed Res Int       Date:  2016-08-03       Impact factor: 3.411

6.  Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia.

Authors:  Sylwia Koltan; Robert Debski; Andrzej Koltan; Elzbieta Grzesk; Barbara Tejza; Andrzej Eljaszewicz; Lidia Gackowska; Malgorzata Kubicka; Beata Kolodziej; Beata Kurylo-Rafinska; Izabela Kubiszewska; Malgorzata Wiese; Milena Januszewska; Jacek Michalkiewicz; Mariusz Wysocki; Jan Styczynski; Grzegorz Grzesk
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.